Doc's note: If you want to beat the S&P, you have to look outside the S&P...

Investing in the S&P 500 Index is one of the greatest ways to grow your wealth. But, as my friend Joel Litman explains, only looking to the S&P for your investments could mean you're missing out on big opportunities...


George Russell only wanted to make his grandfather proud...

He didn't plan to change the entire investing industry.

George started working at his grandfather's business, Frank Russell Company, in 1958. Although it had been around for more than two decades, it was still pretty much a one-man show.

Frank Russell was a retired Wall Street stockbroker just looking to keep busy. So he worked with a handful of local clients.

George joined the team after graduating from Harvard Business School. But he didn't have much time to adjust. Three months later, his grandfather died... and George found himself at the helm.

The company he helped build now manages nearly $400 billion in assets under management.

And as you'll see, he transformed all of Wall Street in the process...

During George's first decade leading the business, pension funds were booming...

Companies would invest money on behalf of their employees so they'd be set for retirement. There was a problem, though... A lot of funds struggled to pick good investments.

None of these pensioners knew what they were looking at. Pension funds had a tough time getting good data on their investments. Their managers and brokers would all come up with different numbers.

And that made measuring performance a hassle.

George created the Portfolio Activity Report ("PAR"), the gold standard for measuring pension performance.

The report tracked a fund's holdings, buys, and sells. It was a crucial single source of information for fund managers.

George and the team soon realized there was a lot of demand for a stock data "one-stop shop." So the company began building indexes that tracked stock performance uniformly. Pension funds could use the data to make better investment decisions.

Even back in the 1980s, pension funds weren't satisfied with doing well...

They wanted to beat the S&P 500. To do that, investors had to look outside the S&P 500.

So the Russell team took all the companies it could track – about 3,000 in total – and turned that data into its own index.

Most folks these days are familiar with the Russell indexes. The Russell 3000 is still pretty much the definitive universe of investible U.S. companies.

George and the team broke that up into two smaller indexes. They expected the Russell 1000 to be the more popular one. Since it holds the 1,000 largest publicly listed U.S. stocks, it's closer to the S&P 500.

But to their surprise, the Russell 2000 became the crowd favorite.

Investors loved this list of smaller, less-covered stocks. Folks realized that while these stocks were small, they could soon grow to be in the Russell 1000... or even the S&P 500.

It gave them a chance to buy in earlier than ever.

It's still a huge deal for stocks to join the Russell 2000...

They gain legitimacy, meaning a lot more investors can start buying in.

In fact, many institutional funds are required to buy what's in the Russell. It's the best way to track the index's performance.

And since investors are starting much closer to the ground floor... there's a lot more room for shares to run.

The S&P 500, the Nasdaq, and the Dow are still the world's most popular stock indexes. But the Russell provides some of the best investment-universe data out there.

If you're looking for some great hidden gems, start your search in the Russell 2000. Plenty of the smallest stocks are just waiting to grow into the larger indexes.

Regards,

Joel Litman

Editor's note: Joel says April 30 will be the most profitable day of 2026. It's because of a little-known financial mandate that says Wall Street firms must buy certain stocks.

His analysis shows that last year, this predictable market event could have doubled your money 21 times, tripled it five times, and made you more than 300% twice. See how you could double your money this year, too (from our corporate affiliate, Altimetry).

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top